1. valerian extract for treatment and prevention of GABA-dependent disorders, characterized in that the ratio valerenovoy acid (VC) to atsetovalerenovoy acid (AVK) in the extract of at least 2: 1.2. Extract according to claim 1, characterized in that the ratio valerenovoy acid (VC) to atsetoksivalerenovoy acid (AVC) is at least 3:. 1, preferably 4: 1, preferably not less than 10: 1, the ratio is most preferably about 12: 1.3. Extract according to claim 1 or 2, characterized in that the solvent used in the production of groups:. Petroleum ether, ethyl acetate and / or aqueous alcohols (gidrospirty) gidrospirty preferably with an alcohol content of 40-80%, more preferably aqueous methanol or ethanol most preferably an aqueous solution etanola.4. Extract according to claim 1 or 2, characterized in that used for the treatment of GABA-dependent disorders from the group:. Anxiety, depression, anxiety and bessonnitsa.5. The use of valerian extract for preparing a medicament for the treatment and prevention of GABAA dependent disorders, characterized in that the ratio valerenovoy acid (VC) to atsetoksivalerenovoy acid (AVC) is at least 2: 1.6. Use according to claim 5, characterized in that the ratio valerenovoy acid (VC) to atsetoksivalerenovoy acid (AVC) is at least 3:. 1, preferably 4: 1, more preferably not less than 10: 1, the ratio is most preferably about 12: 1.7. Use according to claim 5 or 6, characterized in that the solvent used in the production of groups:. Petroleum ether, ethyl acetate and / or aqueous alcohols (gidrospirty) gidrospirty preferably with an alcohol content of 40-80%, more preferably aqueous methanol or ethanol , most preferably water1. Экстракт валерианы для лечения и профилактики ГАМКА-зависимых расстройств, отличающийся тем, что отношение валереновой кислоты (ВК) к ацетовалереновой кислоте (АВК) в экстракте по меньшей мере 2:1.2. Экстракт по п. 1, отличающийся тем, что отношение валереновой кислоты (ВК) к ацетоксивалереновой кислоте (АВК) не м
